Guy Lambrecht - Concepedia

Author

Guy Lambrecht

Also Known As

Arnaud Colard, B. Claerbout, Ben Colleypriest, G L Lambrecht, G LAMBRECHT, G Lambrecht, G. Lambrecht, G.L.Y. Lambrecht, Guy L Lambrecht, Guy L.Y. Lambrecht

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Imelda Hospital KU Leuven Damiaan Dicht bij het leven AZ Delta AZ Sint-Lucas

About

Guy Lambrecht is an author at Imelda Hospital specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	2.1K
2	Public Health	3	3	77
3	Health Sciences	2	2	99
4	Applied Physiology	1	1	60
5	Epidemiology	1	1	37

Guy Lambrecht

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Geert D’Haens, Filip Baert, Gert Van Assche, The Lancet Autoimmune DiseaseImmunosuppressive TherapyImmunologyGastroenterologyClinical Gastroenterology	2008	1.2K
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease Geert D’Haens, Séverine Vermeire, Guy Lambrecht, Gastroenterology InflammationChronic Inflammatory DiseasesInfliximab DoseImmunologyGastroenterology	2018	295
Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy Martine De Vos, Édouard Louis, Jørgen Jahnsen, Inflammatory Bowel Diseases	2013	202
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial Édouard Louis, Matthieu Resche‐Rigon, David Laharie, The Lancet. Gastroenterology & hepatology Autoimmune DiseaseImmunosuppressive TherapyImmunologyGastroenterologyClinical Trials	2023	101
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease Erwin Dreesen, Filip Baert, David Laharie, Clinical Gastroenterology and Hepatology InflammationChronic Inflammatory DiseasesMucosal HealingMucosal ImmunologyCrohn ’	2019	82
Acute renal failure due to bilateral lymphomatous infiltrates. Primary extranodal non-Hodgkin's lymphoma (p-EN-NHL) of the kidneys: does it really exist? Manu L. N. G. Malbrain, Guy Lambrecht, R. Daelemans, PubMed Renal PathologyPathologyPrimary Extranodal Non-hodgkinBilateral Lymphomatous InfiltratesGlomerulonephritis	1994	79
Changes in multifidus and abdominal muscle size in response to microgravity: possible implications for low back pain research Julie A. Hides, Guy Lambrecht, Warren R. Stanton, European Spine Journal KinesiologyHealth SciencesPain MedicinePhysiologyBiomechanics	2015	60
Preference for a prefilled syringe or an auto-injection device for delivering golimumab in patients with moderate-to-severe ulcerative colitis: a randomized crossover study Séverine Vermeire, F D’Heygere, A. Nakad, Patient Preference and Adherence	2018	56
Treatment of Severe Thallium Intoxication Manu L. N. G. Malbrain, Guy Lambrecht, Erik Zandijk, Journal of Toxicology Clinical Toxicology MoxibustionHigh Serum ThalliumAntibioticsHealth SciencesMedicine	1997	39
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial Marie Truyens, Triana Lobatón, Marc Ferrante, Gastroenterology InflammationFunctional Gastrointestinal DisorderGastrointestinal PharmacologyMedicinePhysiology	2022	38

Page 1